These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 7602885)
1. [Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes]. Home PD Journ Annu Diabetol Hotel Dieu; 1995; ():243-55. PubMed ID: 7602885 [No Abstract] [Full Text] [Related]
2. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy. Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy. Lauritzen T Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487 [No Abstract] [Full Text] [Related]
4. [Unstable diabetes. Definition, causes and consequences]. Scheen AJ; Lefèbvre PJ Journ Annu Diabetol Hotel Dieu; 1995; ():229-41. PubMed ID: 7602884 [No Abstract] [Full Text] [Related]
5. Diabetes and the insulin routine. Bloom A Postgrad Med J; 1979; 55 Suppl 2():27-30. PubMed ID: 482196 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes. Luzio SD; Beck P; Owens DR Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275 [TBL] [Abstract][Full Text] [Related]
10. [Flexibility and effectiveness of diabetes therapy]. Krankenpfl J; 2005; 43(1-3):62. PubMed ID: 15912849 [No Abstract] [Full Text] [Related]
11. [The dawn phenomenon in diabetes mellitus]. Shikano M; Sobajima H Nihon Rinsho; 1997 Nov; 55 Suppl():687-94. PubMed ID: 9434549 [No Abstract] [Full Text] [Related]
15. Unlocking the opportunity of tight glycaemic control. Far from goal. Del Prato S Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133 [TBL] [Abstract][Full Text] [Related]
16. Optimal H infinity insulin injection control for blood glucose regulation in diabetic patients. Chee F; Savkin AV; Fernando TL; Nahavandi S IEEE Trans Biomed Eng; 2005 Oct; 52(10):1625-31. PubMed ID: 16235648 [TBL] [Abstract][Full Text] [Related]
17. The biological properties of human insulin. Subcutaneous absorption, receptor binding and the clinical effect in diabetics assessed by a new statistical method. Sestoft L; Vølund A; Gammeltoft S; Birch K; Hildebrandt P Acta Med Scand; 1982; 212(1-2):21-8. PubMed ID: 6751025 [No Abstract] [Full Text] [Related]
18. The perioperative management of diabetes. Nel CJ; de Waal JM; Steyn AF S Afr J Surg; 1980 Sep; 19(3):107-12. PubMed ID: 7003762 [No Abstract] [Full Text] [Related]
19. New insulin delivery systems. N Z Med J; 1980 Sep; 92(668):238-9. PubMed ID: 7005766 [No Abstract] [Full Text] [Related]
20. Smoking enhances absorption of insulin but reduces glucodynamic effects in individuals using the Lilly-Dura inhaled insulin system. Wise S; Chien J; Yeo K; Richardson C Diabet Med; 2006 May; 23(5):510-5. PubMed ID: 16681559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]